About SAMS
Our Mission
Securing America’s Medicines and Supply, Inc. (SAMS) is a multi-industry coalition dedicated to strengthening the security of the U.S. medical supply chain. SAMS unites a diverse network of manufacturers, non-profits, wholesalers, and distributors committed to advancing legislative and regulatory efforts that incentivize and expand U.S.-based production of essential pharmaceuticals. Our mission is to safeguard patient health, fortify domestic healthcare security by reducing dependence on foreign adversaries, protect American jobs, and restore control of our medicine supply to the United States. We champion targeted, operable policy initiatives that foster a resilient and reliable healthcare supply chain for American patients.
SAMS Policy Priorities
SAMS believes policymakers should prioritize reforms in five broad categories:
Supply Chain Mapping & Strategic Planning
Develop a comprehensive understanding of current supply chains and set priorities for rebuilding U.S. manufacturing capacity.
Federal Investment & Incentives
Provide targeted funding for facilities, raw materials, and workforce development, along with derisking measures such as direct investments and strategic incentives for U.S.-based production.
Public-Private Partnerships & Reserves
Establish pilot programs for strategic reserves of essential medicines, leveraging vendor-managed inventory and logistics expertise to improve emergency preparedness.
Market Sustainability & Competitiveness
Reform trade and tax policies to eliminate structural disadvantages, prioritize U.S.-made products in government procurement, and create long-term CMS-driven incentives to retain and onshore critical medicines.
Transparency & Quality Assurance
Implement clear regulations on product origin and quality to build public confidence and strengthen national health security.
By advancing these priorities, the U.S. can build a resilient, reliable, and self-sufficient healthcare supply chain capable of withstanding future crises and ensuring that life-saving medicines are made in America.
SAMS Coalition Membership
API Innovation Center
The API Innovation Center is a non-profit public benefit organization dedicated to delivering a market-competitive commercial supply of U.S.-made active pharmaceutical ingredients (APIs) to meet healthcare supply chain needs. Its mission is to drive health security and economic growth for the nation and its citizens through the domestic production of critical medicines.
Par Health
Par Health is the essential pharmaceutical company. We develop high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs), supported by a robust, U.S.-advantaged manufacturing network. With over 4,000 team members worldwide, we believe great healthcare is built on getting the essentials right.
Amneal Pharmaceuticals
Amneal Pharmaceuticals, LLC, globally headquartered in Bridgewater, NJ, is a fully integrated essential medicines company with a diverse portfolio of approximately 250 products in its Generics, Biosimilar and Specialty segments and a significant domestic manufacturing base. Through its AvKARE segment, the Company is a leading distributor
Amneal Pharmaceuticals, LLC, globally headquartered in Bridgewater, NJ, is a fully integrated essential medicines company with a diverse portfolio of approximately 250 products in its Generics, Biosimilar and Specialty segments and a significant domestic manufacturing base. Through its AvKARE segment, the Company is a leading distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets.
Cencora
Founded in 1947, Cencora (formerly AmerisourceBergen) has its global headquarters in Conshohocken, Pennsylvania. As a leading global pharmaceutical distribution and services organization centered on improving the lives of people and animals around the world, the company partners with pharmaceutical manufacturers across the value chain to
Founded in 1947, Cencora (formerly AmerisourceBergen) has its global headquarters in Conshohocken, Pennsylvania. As a leading global pharmaceutical distribution and services organization centered on improving the lives of people and animals around the world, the company partners with pharmaceutical manufacturers across the value chain to facilitate and optimize access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals and healthcare products.
Fresenius Kabi
Fresenius Kabi
Fresenius Kabi specializes in injectable medicines, biosimilars, and innovative medical technologies and employs more than 4,000 people in the United States. The company has key domestic manufacturing, research and development, and distribution centers in Illinois, Massachusetts, Nevada, New York, North Carolina, Pennsylvania, South Carol
Fresenius Kabi specializes in injectable medicines, biosimilars, and innovative medical technologies and employs more than 4,000 people in the United States. The company has key domestic manufacturing, research and development, and distribution centers in Illinois, Massachusetts, Nevada, New York, North Carolina, Pennsylvania, South Carolina, and Wisconsin. As the largest manufacturer of generic sterile injectables for its addressable U.S. market, Fresenius Kabi fills and finishes more than 70 percent of those medicines in the U.S.